RAC 5.59% $1.70 race oncology ltd

[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene, page-23

  1. 8,385 Posts.
    lightbulb Created with Sketch. 1382
    Yes it should.

    In the meantime, have you read the results of the two recent Israel clinical trials and all the recent RAC and independent preclinicals and the 45 bisantrene clinical trials from the 1980s and 1990s?
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.